Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
ISPC

ISPC - iSpecimen Inc. Stock Price, Fair Value and News

$0.36+0.02 (+5.88%)
Market Closed

31/100

ISPC

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

31/100

ISPC

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

$0.32

Target 3M

$0.36

Target 6M

$0.35

ISPC Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

ISPC Price Action

Last 7 days

12.5%

Last 30 days

5.9%

Last 90 days

-53.2%

Trailing 12 Months

-82.9%

ISPC RSI Chart

ISPC Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

ISPC Valuation

Market Cap

3.5M

Price/Earnings (Trailing)

-0.3

Price/Sales (Trailing)

1.05

EV/EBITDA

-0.51

Price/Free Cashflow

-0.82

ISPC Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

$0.32

Target 3M

$0.36

Target 6M

$0.35

ISPC Fundamentals

ISPC Revenue

Revenue (TTM)

3.4M

Rev. Growth (Yr)

-96%

Rev. Growth (Qtr)

-85.05%

ISPC Earnings

Earnings (TTM)

-11.5M

Earnings Growth (Yr)

-93.12%

Earnings Growth (Qtr)

-165.52%

ISPC Profitability

EBT Margin

-172.63%

Return on Equity

-375.34%

Return on Assets

-128.18%

Free Cashflow Yield

-122.25%

ISPC Investor Care

Shares Dilution (1Y)

915.03%

Diluted EPS (TTM)

-7.45

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20258.1M5.9M3.4M0
20249.3M10.5M10.4M9.3M
202311.0M10.0M10.2M9.9M
202210.7M10.4M10.3M10.5M
20219.4M10.8M11.3M11.1M
202005.6M6.9M8.2M
20190004.3M
Get all data in R, Python etc through our Historical Stock Data APIs

About iSpecimen Inc.

ISPC
iSpecimen Inc. provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals, labs, biobanks, blood centers, and other healthcare organizations. The company develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access to subjects, samples, and data with hospitals, laboratories, and other organizations who have access to them. It serves biopharmaceutical companies, in vitro diagnostic companies, and government/academic institutions. The company was incorporated in 2009 and is headquartered in Lexington, Massachusetts.
 CEO
 WEBSITEhttps://ispecimen.com
 SECTORHealthcare
 INDUSTRYDiagnostics & Research
 EMPLOYEES75

iSpecimen Inc. Frequently Asked Questions

ISPC is the stock ticker symbol of iSpecimen Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

As of Wed Jan 28 2026, market cap of iSpecimen Inc. is 3.52 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check ISPC's fair value in chart for subscribers.

The fair value guage provides a quick view whether ISPC is over valued or under valued. Whether iSpecimen Inc. is cheap or expensive depends on the assumptions which impact iSpecimen Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for ISPC.

As of Wed Jan 28 2026, ISPC's PE ratio (Price to Earnings) is -0.3 and Price to Sales (PS) ratio is 1.05. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. ISPC PE ratio will change depending on the future growth rate expectations of investors.